Dr. Sumit Singh

Dr. Sumit Singh

Chief - Neurology

Neurology

MBBS, MD - Medicine, DM - Neurology

Artemis Hospital

Neurology

Years Of Experience : 28

About Doctor

Dr. Sumit Singh – a topper at All India Institute of Medical sciences and a BL SONI Gold Medal Awardee at AIIMS joined the institute as a Faculty in the year 2000. He established the first Headache clinic in India in the government Sector in AIIMS in the year 2002. He is a known expert in headache disorders and has been instrumental in co authoring the headache management guidelines for the Indian subcontinent. He started the usage of Botulinium toxin for headache for the first time in India in 2002 and extended its usage in patients in trigeminal neuralgia. He is a known Parkinson’s disease specialist with experience in The DEEP BRAIN STIMULATION SURGERY patient planning and programming. His Primary area of Interest has been movement disorders and is one of the few Botox injectors of the country for patients with Writer’s cramp, Spasmodic torticollis and other dystonias, hemifacial spasm and blepharospasm apart from spasticity management with Botox. He has done fair amount of research in Myasthenia gravis and Multiple sclerosis and has modified the plasma exchange protocols for these patients. Dr Sumit was additional director of Neurology at Medanta the Medicity where he worked from the year 2009 to 2016 and was a leader of the Movement disorders, and the headache program. He has to his credit 104 Publications in Peer reviewed journals and 14 Chapters in Books.

Memberships

Indian Academy of Neurology
International Headache Society
Movement Disorders Society

Services

Parkinson’s disease
Writer’s Cramp
Spasmodic Torticollis
Blepharospasm
\Hemifacial Spasm
Spasticity
Multiple sclerosis
Myasthenia Gravis
Neuropathies
Headache
Botox for Headache
Trigeminal Neuralgia
Movement Disorders and Spasticity
Plasma Exchange
Injections for Carpal Tunnel Syndrome

Awards & Honors

BL Soni Gold Medal For Best Resident Neurology – 1997
BL Soni Book Prize – 1999
Best Resident Award – 1999
Coexistent of muscle specific tyrosine kinase andacetylcholine receptor antibodies in a myasthenia gravis patient – 2010
limb girdle muscular dystrophy type 2A in India – 2010
Apolipoprotein-E genotypes and myasthenia gravis – 2010

Services

Scroll to Top
Scroll to Top